This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to better overall weight loss outcomes. The research suggests that ...

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less ...

Feb. 13, 2025 – For years, some people taking the drug semaglutide to treat diabetes or obesity have reported not only eating less, but drinking less alcohol. The reports have prompted many to ...

An update to the FDA drug shortage list on Feb. 21 listed the semaglutide shortage as being resolved. In a press release, Novo Nordisk said it is shipping all doses of the medication regularly to ...

Adults with type 1 diabetes had greater declines in HbA1c and body weight 1 year after being prescribed semaglutide or tirzepatide. Randomized controlled trials are needed to assess efficacy and ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 ...

On Friday, the FDA reclassified the semaglutide shortage—which had covered multiple doses of Wegovy for obesity and Ozempic for type 2 diabetes—as "resolved" on its online drug shortage database.

In the first clinical trial of its kind, a weekly dose of semaglutide, also known as Ozempic and Wegovy, was found to cut the amount that people drink in one day by about 40% and dramatically ...

A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Direct-to-consumer telehealth company Hims & Hers is forging ahead in the aftermath of the semaglutide shortage ending last week. Hims & Hers faces new headwinds in its weight management segment ...